TSX News -
Coro Further Consolidates Ownership at Marimaca with Option Agreement to Acquire Atahualpa Area Royalties
VANCOUVER, British Columbia, Feb. 07, 2019 (GLOBE NEWSWIRE) — Coro Mining Corp. (“Coro” or the “Company”) (TSX: COP) is pleased […]
Antler Hill Mining announces Update of Qualifying Transaction and Concurrent Financing
TORONTO, Feb. 07, 2019 (GLOBE NEWSWIRE) — Antler Hill Mining Ltd. (TSXV: AHM.H) (the “Corporation” or “Antler Hill”) announces that […]
CDW Authorizes $1 Billion Share Repurchase Program Increase and Declares Cash Dividend of $0.295 Per Share
Reinforces Ongoing Commitment to Delivering Value to Stockholders LINCOLNSHIRE, Ill., Feb. 07, 2019 (GLOBE NEWSWIRE) — CDW Corporation (NASDAQ:CDW), today […]
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2018 Financial Results on March 14, 2019
NEWTOWN, Pa., Feb. 07, 2019 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]
Endurance International Group Reports 2018 Fourth Quarter and Full Year Results
Fiscal Year 2018 GAAP revenue of $1.145 billion Net income of $4.5 million Adjusted EBITDA of $338.1 million Cash flow […]
Medtronic Receives FDA Approval on Expanded Indication for Pipeline Flex Embolization Device
Approval Based on Clinical Data from the PREMIER Trial – New Indication Provides Options for Patients with Small or Medium, […]
Lee Enterprises reports double digit digital growth; Q1 FY2019 results
DAVENPORT, Iowa, Feb. 07, 2019 (GLOBE NEWSWIRE) — Lee Enterprises, Incorporated (NYSE: LEE), a leading provider of high quality, trusted, […]
Ogilvy Health's Mangold and McKenna to be inducted into the Medical Advertising Hall of Fame's Future Famers Program
PARSIPPANY, N.J., Feb. 07, 2019 (GLOBE NEWSWIRE) — Ogilvy Health (www.ogilvychww.com), the health practice of Ogilvy, a WPP company (NASDAQ: […]
Merus to Participate in Guggenheim Healthcare Talks Idea Forum
UTRECHT, Netherlands, Feb. 07, 2019 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS), a clinical-stage immuno-oncology company developing Biclonics®, innovative full-length […]
AC Immune Makes Two Appointments to Executive Committee to Accelerate Product Development
LAUSANNE, Switzerland, Feb. 07, 2019 (GLOBE NEWSWIRE) — AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a […]
